Skip to main content

Advertisement

Table 2 MIC/MPC distribution for clarithromycin with clinical isolates of H. pylori (n = 68)

From: Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori

  MPC distribution data
MICs 0.062 0.125 0.25 0.5 1 2 MPC50 MPC50
0.016 17 5 1     0.062 0.125
0.031   9 17 5    0.125 0.5
0.062–0.125   5 5 1    0.25 0.25
0.25      2 1 1 2
Total 17 14 23 10 3 1 0.25 0.5
  1. MIC minimum inhibitory concentration, MPC mutant prevention concentrations, MIC50 drug concentration at which 50% of strains are inhibited, MIC90 drug concentration at which 90% of strains are inhibited, MPC50 drug concentration at which 50% of strains are inhibited, MPC90 drug concentration at which 90% of strains are inhibited. Concentrations are in mg/L